• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威的子宫肉瘤。对1970年至2000年期间包括419名患者在内的全体人群进行的组织病理学和预后调查。

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.

作者信息

Abeler Vera M, Røyne Odd, Thoresen Steinar, Danielsen Håvard E, Nesland Jahn M, Kristensen Gunnar B

机构信息

Division of Pathology, Radiumhospitalet, University Hospital, Oslo, Norway.

出版信息

Histopathology. 2009 Feb;54(3):355-64. doi: 10.1111/j.1365-2559.2009.03231.x.

DOI:10.1111/j.1365-2559.2009.03231.x
PMID:19236512
Abstract

AIMS

To determine the frequency and survival of the various types of uterine sarcoma in the total population of Norway and evaluate histopathological prognostic factors in order to identify risk groups.

METHODS AND RESULTS

Histopathological review of all uterine sarcoma cases reported to the Norwegian Cancer Registry during 1970-2000 was undertaken. Survival dates were provided by The Cancer Registry. Kaplan-Meier survival curves were generated. The log rank test was used for univariate analysis and a Cox proportional hazards regression model for multivariate evaluation of survival. Stage of disease was the most important prognostic factor for all tumour types. Tumour size and the mitotic index (MI) were significant prognostic factors (P < 0.0001) in leiomyosarcomas confined to the uterus and allowed for separation into three risk groups with marked differences in prognosis. The prognosis of endometrial stromal sarcomas confined to the uterus was related to MI (P < 0.0001) and tumour cell necrosis (P < 0.004). Combining these parameters allowed for separation into three risk groups with marked difference in prognosis. In adenosarcomas, tumour cell necrosis was the only significant prognostic factor.

CONCLUSIONS

There are marked differences in survival between uterine sarcoma types. Leiomyosarcomas and endometrial stromal sarcomas can be divided into different groups.

摘要

目的

确定挪威总人口中各类子宫肉瘤的发病率及生存率,并评估组织病理学预后因素以识别风险组。

方法与结果

对1970 - 2000年间向挪威癌症登记处报告的所有子宫肉瘤病例进行组织病理学复查。生存日期由癌症登记处提供。生成了Kaplan - Meier生存曲线。采用对数秩检验进行单因素分析,并使用Cox比例风险回归模型对生存情况进行多因素评估。疾病分期是所有肿瘤类型最重要的预后因素。肿瘤大小和有丝分裂指数(MI)是局限于子宫的平滑肌肉瘤的显著预后因素(P < 0.0001),并可据此分为三个预后有显著差异的风险组。局限于子宫的子宫内膜间质肉瘤的预后与MI(P < 0.0001)和肿瘤细胞坏死(P < 0.004)有关。综合这些参数可分为三个预后有显著差异的风险组。在腺肉瘤中,肿瘤细胞坏死是唯一显著的预后因素。

结论

子宫肉瘤各类型之间的生存率存在显著差异。平滑肌肉瘤和子宫内膜间质肉瘤可分为不同的组。

相似文献

1
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.挪威的子宫肉瘤。对1970年至2000年期间包括419名患者在内的全体人群进行的组织病理学和预后调查。
Histopathology. 2009 Feb;54(3):355-64. doi: 10.1111/j.1365-2559.2009.03231.x.
2
Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.100例子宫肉瘤的临床结局及预后因素:赫尔辛基大学中心医院1990 - 2001年的经验
Gynecol Oncol. 2008 Oct;111(1):74-81. doi: 10.1016/j.ygyno.2008.06.002. Epub 2008 Jul 26.
3
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.157例子宫肉瘤的临床病理预后因素分析及软组织肉瘤验证分级评分的评估
Cancer. 2000 Mar 15;88(6):1425-31.
4
Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.子宫癌肉瘤、子宫内膜间质肉瘤及子宫平滑肌肉瘤的预后与预后因素:与子宫内膜腺癌的比较
Oncology. 2006;71(5-6):333-40. doi: 10.1159/000107107. Epub 2007 Aug 9.
5
[A clinical analysis of 153 uterine sarcomas].153例子宫肉瘤的临床分析
Zhonghua Fu Chan Ke Za Zhi. 1997 Mar;32(3):163-7.
6
Prognostic factors and outcome in women with uterine sarcoma.子宫肉瘤女性患者的预后因素及结局
Eur J Surg Oncol. 2007 Feb;33(1):91-5. doi: 10.1016/j.ejso.2006.11.012. Epub 2006 Dec 15.
7
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.子宫平滑肌肉瘤:71例临床病理多中心研究
Gynecol Oncol. 1999 Aug;74(2):196-201. doi: 10.1006/gyno.1999.5436.
8
Sarcomas of the uterus: a clinicopathologic study of 119 patients.子宫肉瘤:119例患者的临床病理研究
Obstet Gynecol. 1986 Mar;67(3):417-24.
9
Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?IA 期与 IB 期子宫内膜间质肉瘤:新分期系统能否预测生存?
Gynecol Oncol. 2010 Jul;118(1):8-13. doi: 10.1016/j.ygyno.2010.04.008. Epub 2010 May 5.
10
Uterine sarcomas: a review.子宫肉瘤:综述
Gynecol Oncol. 2010 Jan;116(1):131-9. doi: 10.1016/j.ygyno.2009.09.023. Epub 2009 Oct 23.

引用本文的文献

1
Clinicopathological Predictors of Recurrence in Uterine Sarcomas-A Narrative Review.子宫肉瘤复发的临床病理预测因素——一项叙述性综述
J Clin Med. 2025 Jul 9;14(14):4883. doi: 10.3390/jcm14144883.
2
Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma.血清类黏蛋白1是子宫肉瘤潜在的预后生物标志物。
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251343487. doi: 10.1177/15330338251343487. Epub 2025 May 19.
3
Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report.
奥拉帕利治疗伴有体细胞BRCA2突变的转移性子宫腺肉瘤的4年无复发生存率:一例报告
Gynecol Oncol Rep. 2025 Mar 19;58:101724. doi: 10.1016/j.gore.2025.101724. eCollection 2025 Apr.
4
Navigating diagnostic challenges: case reports on differentiating uterine fibroids from leiomyosarcoma through imaging and clinical evaluation.应对诊断挑战:通过影像学和临床评估鉴别子宫肌瘤和平滑肌肉瘤的病例报告
J Ultrasound. 2025 Feb 4. doi: 10.1007/s40477-025-00991-3.
5
BCOR abnormalities in endometrial stromal sarcoma.子宫内膜间质肉瘤中的BCOR异常
Gynecol Oncol Rep. 2025 Jan 7;57:101672. doi: 10.1016/j.gore.2024.101672. eCollection 2025 Feb.
6
TOURISM study (Treatment Outcomes in UteRIne SarcoMa): a 10-year retrospective evaluation of practice in the UK.子宫肉瘤治疗结果研究(TOURISM):英国10年实践回顾性评估
BMJ Open. 2024 Dec 26;14(12):e094838. doi: 10.1136/bmjopen-2024-094838.
7
Individualized evaluation of risk and prognosis in uterine leiomyosarcoma patients with synchronous distant metastases: a real-world retrospective study.子宫平滑肌肉瘤伴同步远处转移患者风险与预后的个体化评估:一项真实世界回顾性研究
Front Oncol. 2024 Sep 25;14:1417226. doi: 10.3389/fonc.2024.1417226. eCollection 2024.
8
Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford Experience.来自三级医疗中心的子宫肉瘤生存趋势:牛津经验
Diseases. 2024 Sep 2;12(9):200. doi: 10.3390/diseases12090200.
9
Prognostic Factors in Uterine Sarcoma Based on the Tumor Size Stratification: A Retrospective Study.基于肿瘤大小分层的子宫肉瘤预后因素:一项回顾性研究。
Cureus. 2024 Jul 31;16(7):e65819. doi: 10.7759/cureus.65819. eCollection 2024 Jul.
10
Uterine preservation in low-grade endometrial stromal sarcoma.低级别子宫内膜间质肉瘤中的子宫保留
Gynecol Oncol Rep. 2024 Jul 28;55:101470. doi: 10.1016/j.gore.2024.101470. eCollection 2024 Oct.